東純一 | 大阪大学医学部

スポンサーリンク

概要

関連著者

もっと見る

著作論文

TXA_2受容体拮抗薬(BAY u 3405)の健常人における臨床薬理学的研究
BIBR277カプセルの健常人における臨床第1相試験
臨床検査値に及ぼす生活環境因子の検討 : 日焼けの影響
臨床検査値に及ぼす生活環境因子の検討 : 太陽光曝露による生体内生理活性物質・情報伝達因子への影響
臨床検査値に及ぼす生活環境因子の検討 : 睡眠の影響
アドリアマイシン心筋障害発現に対するタウリンの防御効果
心筋細胞における IL-6遺伝子の発現 : in situ hybridizationによる検討 : ポスター発表 : 第57回日本循環器学会学術集会
低酸素刺激による心筋細胞におけるIL-6の発現 : ポスター発表 : 第57回日本循環器学会学術集会
新術中電解質輸液剤の健常成人での生体反応に及ぼす影響
肥大型心筋症(HCM)における心筋β型ミオシン重鎖(βMHC)遺伝子の解析 : 第58回日本循環器学会学術集会
家族性肥大型心筋症(HCM)の病因遺伝子の検討 : 心筋ミオシン重鎖(MHC)遺伝子を用いての解析 : 口述発表 : 第57回日本循環器学会学術集会
IL-6の心筋細胞に対する作用とその細胞内情報伝達機構の検討 : ポスター発表 : 第57回日本循環器学会学術集会
臨床薬理比較試験について
Clinicopharmacological research of FK505 in normal subjects.
Pharmacodynamics of orally administered acarbose in healthy volunteers and dose correlation of blood sugar and inhibiting actions of insulin elevation under oral disaccharide load.
Phase 1 study of Recombinant human erythropoietin.Intravenous and repetitive subcutaneous admimistration test.
Clinicopharmacological research of FK453 in normal subjects.
Gallopamil の臨床薬理学的検討-第一相単回経口投与試験-
狂心発作寛解薬としての硝酸イソソルビドスプレー(E-100)の有用性-血圧降下作用と生物学的利用性からの検討-
Changes in the Serum Enzyme Levels and the Predicting Factors during 2 Weeks Hospitalization in Healthy Male Volunteers: A Retrospective Study. Changes in Serum Levels of GOT,GPT,.GAMMA.-GTP,LDH,ALP and LAP.:Changes in Serum Levels of GOT, GPT, γ-GTP, LDH
Pharmacodynamics in healthy adults of a new Class III antiarrhythmic agent E4031.
タイトル無し
Seasonal variation of IgE level and eosinophil count in healthy adult male.
Study on serum GPT elevation in health adult male.GOT/GPT and relevance to body fatness.
Evaluation of a new software for the personal computer "PAG-CP" for calculation of several pharmacokinetic coefficients.
Method of calculation of left-right symmetric reliability area by conversion of logarithm, square root in biological equivalence test.
A pharmacokinetic analysis method for sustained-release preparation.
Phase I clinical studies with high dose of lisuride maleate. Incidence of appearance of subjective symptoms observed from method of administration.
Clinical-pharmacological research of dopexamine in normal subject.
Clinical-pharmacological study using in-urine potassium excretion amount in potassium pharmaceutical (MR9H2) administration as index.
From the viewpoint of trial case doctors.
Platelet aggregation ability in clinical phase I test. Variation in aggregation ability during adminisration of .ALPHA.-indobufen tablets.
Pharmacokinetics in a healthy adult of a new Class III antiarrhythmic agent E4031.
Reliability of occult blood test of feces in clinical laboratory.Appearance frequency of positive examples.
Abnormal elevation of serum escape enzyme level by exercise load.
Pharmacological study for oral administration of aldose reductase inhibitor, tolrestat.Effect on sorbitol level in erythrocyte.
Studies on living environment factor influenced in clinical laboratory findings.Effect of sunburn.
Effect of living environment factors on laboratory findings.Effect of solar light exposure on in vivo biologically active substances and information transfer factors.
Phase I study of HLBI prolonged action preparation. Comparative studies with rapid release preparation.
Phase I clinical studies on recombinant human G-CSF (KRN8601). A study on its single administration by intravenous drip infusion.
Phase I studies of a recombinant human G-CSF (KRN8601). Comparison between intravenous administration and subcutaneous administration.
Studies on effect on regression of cardiac hypertrophy by prolonged administration of metoprolol in hypertensive patients.
Circadian variation of data of laboratory tests in healthy adult men. Peripheral blood cell counts and platelet aggregation ability.
Effect of exercise test on a urinalysis.The urinalysis in producing muscular pain.
Examination of exercising influence on laboratory finding.Effect of sleep.
Studies on the choice of subjects in phase I clinical tests. Significance of sinus arrhythmia and sinus bradycardia.
Variations in data of liver function tests by administration of placebo (single and consecutively). GOT, GPT and .GAMMA.-GTP.

もっと見る

スポンサーリンク